Schering-Plough has state-of-the-art research and development facilities around the world.
Cambridge, Massachusetts - Biologics in oncology, small molecules in oncology, inflammation/autoimmunity and screening technologies.
Mexico City, Mexico – Pharmaceutical development
New Jersey – Several laboratory sites in New Jersey together encompass all areas of R&D. The largest New Jersey laboratory facility is on the Kenilworth campus, the site of the company’s global headquarters.
Newhouse, Scotland – Specializing in central nervous system (psychiatry and analgesia) and cardiovascular/metabolic disease research.
Oss, the Netherlands – Research, specializing in women’s health (contraception, fertility, osteoporosis and endometriosis), oncology research related to endocrinology and immunology (inflammation for rheumatoid arthritis).
Palo Alto, California (Schering-Plough Biopharma) – Biotech research, specializing in oncology and inflammation
Riom, France – Preclinical development
Schachen (canton of Lucerne), Switzerland – Our Werthenstein Chemie AG focuses on chemistry, biotechnology and clinical packaging, which also comprises the area of analysis and research
Tokyo and Osaka, Japan – Focusing on pre-clinical and clinical development for products for Japan
Waltrop, Germany – Preclinical development
